A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil-Reference-Cited by-同舟云学术

A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil

Published:1999-03-12 Issue:11-12 Volume:79 Page:1864-1869
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Etienne M C,Pivot X,Formento J L,Bensadoun R J,Formento P,Dassonville O,Francoual M,Poissonnet G,Fontana X,Schneider M,Demard F,Milano G

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6690297.pdf

Reference27 articles.

1. Beck, A., Etienne, M. C., Cheradame, S., Fischel, J. L., Formento, P., Renée, N. & Milano, G. (1994). A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumor sensitivity to fluorouracil. Eur J Cancer 30: 1517–1522.

2. Chu, E. & Allegra, C. J. (1996). The role of thymidylate synthase in cellular regulation. Adv Enzyme Regul 36: 143–163.

3. Dassonville, O., Formento, J. L., Francoval, M., Ramaioli, A., Santini, J., Schneider, M., Demard, F. & Milano, G. (1993). Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J Clin Oncol 11: 1873–1878.

4. Dimery, I. W. & Hong, W. K. (1993). Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 85: 95–111.

5. Etienne, M. C., Bernard, S., Fischel, J. L., Formento, P., Gioanni, J., Santini, J., Demard, F., Schneider, M. & Milano, G. (1991). Dose reduction without loss of efficacy for 5 fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell lines. Br J Cancer 63: 372–377.

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Implications of EGFR, p53, p16, Cyclin D1, and Bcl‐2 in Head and Neck Squamous Cell Carcinoma (HNSCC);Precision Medicine in Oncology;2020-08-14

2. Sustained complete response to erlotinib in squamous cell carcinoma of the head and neck: A case report;World Journal of Clinical Cases;2019-03-06

3. A response prediction model for taxane, cisplatin, and 5-fluorouracil chemotherapy in hypopharyngeal carcinoma;Scientific Reports;2018-08-23

4. Randomized, placebo-controlled window trial of EGFR, Src, or combined blockade in head and neck cancer;JCI Insight;2017-03-23

5. Higher Tissue Levels of Thymidylate Synthase Determined by ELISA Are Associated with Poor Prognosis of Patients with Lung Cancer;The Tohoku Journal of Experimental Medicine;2017